1. Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy 
Wilson Y.S. Leung, BPharm, PhD, Wing-Yee So, MBChB, MRCP, Peter C.Y. Tong, PhD, Norman N. Chan, MD, Juliana C.N. Chan, MD 
The American Journal of Medicine 
Volume 118, Issue 12, Pages 1414.e e27 (December 2005)
DOI: /j.amjmed
Copyright © 2005 Elsevier Inc. Terms and Conditions

2. Figure 1
Kaplan-Meier curves for the primary composite endpoint of end-stage renal disease or all-cause death (A), end-stage renal disease (B), and all-cause death (C).
The American Journal of Medicine  , 1414.e e27DOI: ( /j.amjmed )
Copyright © 2005 Elsevier Inc. Terms and Conditions